A proteomic approach in the study of an animal model of Parkinson's disease.
about
Genomic and proteomic responses to environmentally relevant exposures to dieldrin: indicators of neurodegeneration?Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegansSpecific changes of serum proteins in Parkinson's disease patientsQualitative and quantitative multiplexed proteomic analysis of complex yeast protein fractions that modulate the assembly of the yeast prion Sup35pRoles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.Neuroproteomics as a promising tool in Parkinson's disease research.Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeysRedox proteomics in some age-related neurodegenerative disorders or models thereofProteomics in animal models of Alzheimer's and Parkinson's diseases.Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.The Role of skn-1 in methylmercury-induced latent dopaminergic neurodegeneration.Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.New insight into neurodegeneration: the role of proteomics.Targeted Annotation of S-Sulfonylated Peptides by Selective Infrared Multiphoton Dissociation Mass Spectrometry.Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment.Proteomic studies associated with Parkinson's disease.Yam (Dioscorea pseudojaponica Yamamoto) ameliorates cognition deficit and attenuates oxidative damage in senescent mice induced by D-galactose.(2S)-5, 2', 5'-trihydroxy-7-methoxyflavanone, a natural product from Abacopteris penangiana, presents neuroprotective effects in vitro and in vivo.Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF-K B/JNK signaling pathway in aging mouse model.Neuroprotective effect of peptides extracted from walnut (Juglans Sigilata Dode) proteins on Aβ25-35-induced memory impairment in mice.Diosgenin ameliorates cognition deficit and attenuates oxidative damage in senescent mice induced by D-galactose.Ursolic acid in health and disease.
P2860
Q28382869-2ACBCC97-2BB4-4174-BD08-A34073626EF1Q28475323-6086F0EC-1F18-4D2E-B667-3C20627E24BFQ28538260-868C98D1-3843-4950-AFE6-DC3DB4B85E52Q28740450-F3B00418-8720-481D-AD6F-8E12D4163A61Q30394816-F5B8EBF9-DB87-4E25-BD90-A670C79F028CQ30446460-9453CE5A-87CC-49D6-A8B3-2563C4A41EECQ33285975-06A78B77-CB86-486F-943A-681365FFA41CQ33821316-EBBA0DB4-5CB7-45CD-AEF4-84A36B8E1B3FQ34990005-E9CAE07F-F2FA-4860-A1E7-22D48B21F483Q36525171-97736B55-0D43-45ED-A576-922078ABA303Q37071539-C904CF46-743A-45C2-BFE4-B5DDC3800CDBQ37105161-508DA504-D667-4B12-9463-57648418B7FEQ37427911-1E4672A6-33EE-494B-92E7-FB4F4BF5C6B6Q37603401-E0FCFCCE-863E-4337-8CE4-AEA3E27ABA6AQ37685124-5AFC4463-DE2E-48C5-BCCF-23AE8690D04AQ37727186-A9B6ECC1-37D3-4D55-A166-4723A0828FA1Q38170010-67656FD9-E477-42AF-B871-D3E05E458055Q38679121-26C4C532-AC2E-42EE-9E71-2217E82E93E1Q38725685-839818E5-BA56-4586-A27C-16E57CA0D67DQ38761409-6E78493B-0362-4019-8B73-312E083051D6Q43249661-12085229-6DEC-4A13-8B92-4FFDD894FAA3Q46699429-7907AEA9-1D8A-4F4F-B980-A2CD2E6DF71FQ46813751-7B075D1E-ADE7-4E4A-9C29-9D21257645ABQ48932169-F8AC96EA-72B4-4138-9C4A-FB4614712804Q51007899-2376977C-A7BC-427C-9E02-D85B1583695CQ54112974-AD921451-92A8-485D-AFC1-9A64C8916BEE
P2860
A proteomic approach in the study of an animal model of Parkinson's disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A proteomic approach in the study of an animal model of Parkinson's disease.
@ast
A proteomic approach in the study of an animal model of Parkinson's disease.
@en
type
label
A proteomic approach in the study of an animal model of Parkinson's disease.
@ast
A proteomic approach in the study of an animal model of Parkinson's disease.
@en
prefLabel
A proteomic approach in the study of an animal model of Parkinson's disease.
@ast
A proteomic approach in the study of an animal model of Parkinson's disease.
@en
P2093
P1433
P1476
A proteomic approach in the study of an animal model of Parkinson's disease
@en
P2093
Alessandra Recchia
Angela De Iuliis
Jessica Grigoletto
Paola Arslan
P304
P356
10.1016/J.CCCN.2005.03.028
P577
2005-07-01T00:00:00Z